HALO X-ray Technologies Ltd

HALO X-ray Technologies Ltd is a pioneering company that focuses on developing OEM X-ray diffraction solutions based on Focal Construct Technology. Their technology, which has been spun out of prestigious institutions like Nottingham Trent University and Cranfield University, has a wide range of applications. With a strong background in aviation security and medical systems, HALO has established itself as a key player in these markets. They also have a notable presence in the medical field, evident from their involvement in an EPSRC grant project for Point-of-Care High Accuracy Fracture Risk Prediction. Their strategy revolves around the development of OEM products, which are distributed through a network of 3rd party suppliers. Founded in 2012 and headquartered in the United Kingdom, HALO recently secured a significant £2.00M Series A investment on 06 September 2023, with funding from Future Planet Capital and Agilent Technologies. This investment not only indicates the confidence of these prominent investors in HALO's vision but also provides the company with the necessary capital to further develop and market their innovative X-ray technology. With a strong foundation, strategic focus, and backing from notable investors, HALO X-ray Technologies Ltd is poised for substantial growth and impact in the industry.